ENTITY
Frontage Holdings

Frontage Holdings (1521 HK)

62
Analysis
Health Care • United States
Frontage Holdings is a contract research organization (CRO) providing integrated, scientifically-driven research, analytical, and development services to pharmaceutical, biotech, and agrochemical companies. Its services span drug discovery, preclinical and clinical development, including DMPK, safety and toxicology, bioanalysis, and GMP manufacturing. The company was founded in 2001 and is headquartered in Exton, PA, USA.
more
bullish•Luckin Coffee
•11 May 2019 13:08

ECM Weekly (11 May 2019) - AB InBev APAC, ELuckin, Aakash Edu, GSX Techedu, CSSC (HK) Shipping

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
•08 May 2019 15:36

Frontage Holdings IPO Preview: An Uncertain Transition

Frontage Laboratories Inc (1000371Z HK) is a global contract research organisation (CRO) which is backed by Hangzhou Tigermed Consulting (300347...

Logo
797 Views
Share
bearish•Viva Biotech
•28 Mar 2019 15:48

Viva Biotech (维亚生物) IPO: Warning Signs from 2018 Numbers (Part 2)

Viva Biotechnology, a China-based drug discovery company, is seeking to raise USD 200m to list on the Hong Kong Stock Exchange. It has recently...

Logo
1.1k Views
Share
bullish•Wuxi Biologics
•23 Mar 2019 12:52

ECM Weekly (23 March 2019) - ESR, Sun Car, Ruhnn, CanSino, Frontage, Wuxi Bio, WiseTech,

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
•20 Mar 2019 16:23

Frontage Holding (方达控股) IPO: Updates from 2018 Numbers

Frontage Holding, a contract research organization subsidiary of A-share listed Hangzhou Tigermed Consulting (300347 CH), re-filed to list on the...

Logo
1.1k Views
Share
x